Armistice Capital’s Theriva Biologics TOVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100,000	Closed	-$138K	–	297
2024 Q3	$138K	Buy	+100,000	New	+$138K	﹤0.01%	224
2019 Q1	–	Sell	-2,228	Closed	-$312K	–	84
2018 Q4	$312K	Buy	+2,228	New	+$312K	0.02%	63